125
Views
1
CrossRef citations to date
0
Altmetric
Short Report

Antibiotic Prescriptions in Hospitalized Patients with an Exacerbation COPD and a Proven Influenza or RS Virus Infection

, , , , ORCID Icon & ORCID Icon
Pages 1261-1267 | Published online: 01 Jun 2022

References

  • Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289(2):179–186. doi:10.1001/jama.289.2.179
  • LBZ. Ziekenhuisopnamen COPD. 2017; Available from: https://www.volksgezondheidenzorg.info/onderwerp/copd/preventie-zorg/zorg#node-ziekenhuisopnamen-copd. Accessed May 23, 2022. Dutch.
  • Ahn S, Kim WY, Kim S-H, et al. Role of procalcitonin and C-reactive protein in differentiation of mixed bacterial infection from 2009 H1N1 viral pneumonia. Influenza Other Respir Viruses. 2011;5(6):398–403. doi:10.1111/j.1750-2659.2011.00244.x
  • Falsey AR, Becker KL, Swinburne AJ, et al. Bacterial complications of respiratory tract viral illness: a comprehensive evaluation. J Infect Dis. 2013;208(3):432–441. doi:10.1093/infdis/jit190
  • LAN/NVALT. Diagnostiek en behandeling COPD-longaanval in het ziekenhuis. 2017; Available from: https://richtlijnendatabase.nl/richtlijn/behandeling_copd-longaanval_in_het_ziekenhuis/startpagina_copd-longaanval_met_ziekenhuisopname.html. Accessed May 23, 2022. Dutch.
  • Alonso Martinez JL, Rubio Obanos MT, Sampériz Legarre AL, et al. [Antibiotic treatment for acute episodes of chronic obstructive pulmonary disease]. An Med Interna. 1992;9(8):377–380. Spanish.
  • Daniels JM, Snijders D, de Graaff CS, et al. Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;181(2):150–157. doi:10.1164/rccm.200906-0837OC
  • Wedzicha JA, Miravitlles M, Hurst JR, et al. Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J. 2017;49(3):1600791. doi:10.1183/13993003.00791-2016
  • Prins HJ, Duijkers R, van der Valk P, et al. CRP-guided antibiotic treatment in acute exacerbations of COPD in hospital admissions. Eur Respir J. 2019;53(5):1802014. doi:10.1183/13993003.02014-2018
  • Haran JP, Beaudoin FL, Suner S, et al. C-reactive protein as predictor of bacterial infection among patients with an influenza-like illness. Am J Emerg Med. 2013;31(1):137–144. doi:10.1016/j.ajem.2012.06.026
  • Bafadhel M, Clark TW, Reid C, et al. Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD. Chest. 2011;139(6):1410–1418. doi:10.1378/chest.10-1747
  • Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet. 2004;363(9409):600–607. doi:10.1016/S0140-6736(04)15591-8
  • Mathioudakis AG, Chatzimavridou-Grigoriadou V, Corlateanu A, et al. Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis. Eur Respir Rev. 2017;26(143):160073. doi:10.1183/16000617.0073-2016
  • Wu MH, Lin -C-C, Huang S-L, et al. Can procalcitonin tests aid in identifying bacterial infections associated with influenza pneumonia? A systematic review and meta-analysis. Influenza Other Respir Viruses. 2013;7(3):349–355. doi:10.1111/j.1750-2659.2012.00386.x
  • Stolz D, Christ-Crain M, Bingisser R, et al. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest. 2007;131(1):9–19. doi:10.1378/chest.06-1500